| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $0 | $13.8M | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | $0 | — | $0 |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$403.5M | -$354.1M | -$103.3M |
| Operating Margin % | — | -2561.3% | — |
| Net Income (GAAP) | -$341.9M | -$300.1M | -$87.6M |
| EBITDA (Normalized) | $448.3M | -$214.8M | -$103.3M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$71.5M | -$126.1M | -$148.9M |
| Capital Expenditures (CapEx) | $1.06B | $174.1M | $0 |
| Free Cash Flow (FCF) | -$1.14B | -$300.3M | -$148.9M |
| FCF Margin % | — | -2171.9% | — |
| Return on Invested Capital (ROIC %) | -14.1% | -45.0% | -1.5% |
| Cash & Short-Term Equivalents | $2.34B | $565.0M | — |
| Total Debt (Short + Long Term) | $2.21B | $155.6M | $2.16B |
| Total Stockholders' Equity | $2.39B | $669.1M | $4.43B |